These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 15237988

  • 1. First principles investigation of vancomycin and teicoplanin binding to bacterial cell wall termini.
    Lee JG, Sagui C, Roland C.
    J Am Chem Soc; 2004 Jul 14; 126(27):8384-5. PubMed ID: 15237988
    [Abstract] [Full Text] [Related]

  • 2. Quantum simulations of the structure and binding of glycopeptide antibiotic aglycons to cell wall analogues.
    Lee JG, Sagui C, Roland C.
    J Phys Chem B; 2005 Nov 03; 109(43):20588-96. PubMed ID: 16853665
    [Abstract] [Full Text] [Related]

  • 3. Binding of a dimeric derivative of vancomycin to L-Lys-D-Ala-D-lactate in solution and at a surface.
    Rao J, Yan L, Lahiri J, Whitesides GM, Weis RM, Warren HS.
    Chem Biol; 1999 Jun 03; 6(6):353-9. PubMed ID: 10375541
    [Abstract] [Full Text] [Related]

  • 4. Partitioning the loss in vancomycin binding affinity for D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions.
    McComas CC, Crowley BM, Boger DL.
    J Am Chem Soc; 2003 Aug 06; 125(31):9314-5. PubMed ID: 12889959
    [Abstract] [Full Text] [Related]

  • 5. Characterization of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance.
    Hong HJ, Hutchings MI, Neu JM, Wright GD, Paget MS, Buttner MJ.
    Mol Microbiol; 2004 May 06; 52(4):1107-21. PubMed ID: 15130128
    [Abstract] [Full Text] [Related]

  • 6. D-Ala-D-lac binding is not required for the high activity of vancomycin dimers against vancomycin resistant enterococci.
    Jain RK, Trias J, Ellman JA.
    J Am Chem Soc; 2003 Jul 23; 125(29):8740-1. PubMed ID: 12862465
    [Abstract] [Full Text] [Related]

  • 7. Selective cleavage of D-Ala-D-Lac by small molecules: re-sensitizing resistant bacteria to vancomycin.
    Chiosis G, Boneca IG.
    Science; 2001 Aug 24; 293(5534):1484-7. PubMed ID: 11520986
    [Abstract] [Full Text] [Related]

  • 8. Quantification of the d-Ala-d-Lac-Terminated Peptidoglycan Structure in Vancomycin-Resistant Enterococcus faecalis Using a Combined Solid-State Nuclear Magnetic Resonance and Mass Spectrometry Analysis.
    Chang JD, Foster EE, Yang H, Kim SJ.
    Biochemistry; 2017 Jan 31; 56(4):612-622. PubMed ID: 28040891
    [Abstract] [Full Text] [Related]

  • 9. Crystal structures of the complexes between vancomycin and cell-wall precursor analogs.
    Nitanai Y, Kikuchi T, Kakoi K, Hanamaki S, Fujisawa I, Aoki K.
    J Mol Biol; 2009 Feb 06; 385(5):1422-32. PubMed ID: 18976660
    [Abstract] [Full Text] [Related]

  • 10. A liquid chromatography-tandem mass spectrometry assay for d-Ala-d-Lac: a key intermediate for vancomycin resistance in vancomycin-resistant enterococci.
    Putty S, Vemula H, Bobba S, Gutheil WG.
    Anal Biochem; 2013 Nov 15; 442(2):166-71. PubMed ID: 23938774
    [Abstract] [Full Text] [Related]

  • 11. Experimental and theoretical studies of the structures and interactions of vancomycin antibiotics with cell wall analogues.
    Yang Z, Vorpagel ER, Laskin J.
    J Am Chem Soc; 2008 Oct 01; 130(39):13013-22. PubMed ID: 18774809
    [Abstract] [Full Text] [Related]

  • 12. Gain of D-alanyl-D-lactate or D-lactyl-D-alanine synthetase activities in three active-site mutants of the Escherichia coli D-alanyl-D-alanine ligase B.
    Park IS, Lin CH, Walsh CT.
    Biochemistry; 1996 Aug 13; 35(32):10464-71. PubMed ID: 8756703
    [Abstract] [Full Text] [Related]

  • 13. Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics.
    Leimkuhler C, Chen L, Barrett D, Panzone G, Sun B, Falcone B, Oberthür M, Donadio S, Walker S, Kahne D.
    J Am Chem Soc; 2005 Mar 16; 127(10):3250-1. PubMed ID: 15755121
    [Abstract] [Full Text] [Related]

  • 14. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
    Printsevskaya SS, Pavlov AY, Olsufyeva EN, Mirchink EP, Preobrazhenskaya MN.
    J Med Chem; 2003 Mar 27; 46(7):1204-9. PubMed ID: 12646030
    [Abstract] [Full Text] [Related]

  • 15. In vivo studies suggest that induction of VanS-dependent vancomycin resistance requires binding of the drug to D-Ala-D-Ala termini in the peptidoglycan cell wall.
    Kwun MJ, Novotna G, Hesketh AR, Hill L, Hong HJ.
    Antimicrob Agents Chemother; 2013 Sep 27; 57(9):4470-80. PubMed ID: 23836175
    [Abstract] [Full Text] [Related]

  • 16. A redesigned vancomycin engineered for dual D-Ala-D-ala And D-Ala-D-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant bacteria.
    Xie J, Pierce JG, James RC, Okano A, Boger DL.
    J Am Chem Soc; 2011 Sep 07; 133(35):13946-9. PubMed ID: 21823662
    [Abstract] [Full Text] [Related]

  • 17. Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin.
    Wu ZC, Boger DL.
    Acc Chem Res; 2020 Nov 17; 53(11):2587-2599. PubMed ID: 33138354
    [Abstract] [Full Text] [Related]

  • 18. D-Alanyl-D-lactate and D-alanyl-D-alanine synthesis by D-alanyl-D-alanine ligase from vancomycin-resistant Leuconostoc mesenteroides. Effects of a phenylalanine 261 to tyrosine mutation.
    Park IS, Walsh CT.
    J Biol Chem; 1997 Apr 04; 272(14):9210-4. PubMed ID: 9083053
    [Abstract] [Full Text] [Related]

  • 19. Heterologous expression of glycopeptide resistance vanHAX gene clusters from soil bacteria in Enterococcus faecalis.
    Hasman H, Aarestrup FM, Dalsgaard A, Guardabassi L.
    J Antimicrob Chemother; 2006 Apr 04; 57(4):648-53. PubMed ID: 16476725
    [Abstract] [Full Text] [Related]

  • 20. Molecular interactions between glycopeptide vancomycin and bacterial cell wall peptide analogues.
    Xing B, Jiang T, Wu X, Liew R, Zhou J, Zhang D, Yeow EK.
    Chemistry; 2011 Dec 09; 17(50):14170-7. PubMed ID: 22083883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.